ALLO: Allogene Therapeutics Inc

1.13 USD 0.05 (4.24%)

부문: 헬스케어 베이스: US Dollar 수익 통화: US Dollar

ALLO 환율이 오늘 -4.24%로 변동했습니다. 당일 이 종목은 저가가 1.11이고 고가는 1.20이었습니다.

Allogene Therapeutics Inc 변동을 참고하세요. 실시간 쿼트는 여러분이 시장 변동에 빠르게 대처하는데에 도움이 될 것입니다. 차트 주기를 전환하여 환율의 추세와 변동을 분, 시간, 일, 주 및 월별로 모니터링할 수 있습니다. 이 정보를 사용하여 시장 변화를 예측하고 정보에 입각한 거래 결정을 내리십시오.

전체 화면 채팅

ALLO News

21:43 Fate Therapeutics: Recent Update Met With Selling, But Positives Exist
19:02 Allogene Therapeutics: Important Catalysts Guided For Early 2026 (NASDAQ:ALLO)
15:11 Allogene's Q2 Loss Narrower Than Expected, Pipeline in Focus
01:13 Allogene Therapeutics, Inc. (ALLO) Q2 2025 Earnings Call Transcript
22:09 Allogene Q2 Cash Tops $300 Million
22:02 Earnings call transcript: Allogene Therapeutics’ Q2 2025 earnings reveal strategic shifts
18:37 Allogene stock continues ALPHA3 trial with standard FC regimen after safety event
18:35 Allogene stock maintains Market Perform rating at Citizens JMP after trial adjustment
11:47 This AvalonBay Communities Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday - Allogene Therapeutics (NASDAQ:ALLO), AvalonBay Communities (NYSE:AVB)
16:52 Allogene Resets Clinical Course After Patient Death In Lymphoma Study - Allogene Therapeutics (NASDAQ:ALLO)
12:33 Adicet Bio stock rating initiated at Buy by H.C. Wainwright
13:41 Betting Big on Cancer: 3 Oncology Stocks Set to Surge in 2025
00:26 Allogene Therapeutics at Jefferies Conference: Delays and Optimism
21:42 Citi maintains buy rating on Allogene stock following ASCO data
11:44 H.C. Wainwright maintains buy rating on Allogene stock after ASCO update
14:56 Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated Advanced Renal Cell Carcinoma at ASCO
09:50 Citizens JMP highlights key ASCO presentations
19:37 Allogene Therapeutics: Buying Around A Potential ASCO Lazarus Moment
13:43 Allogene Therapeutics: Still Looking Shaky, But Looking To Turn The Corner
00:01 Allogene at TD Cowen’s Summit: Strategic Insights on CAR T-Cell Therapy
12:40 Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
21:25 Allogene shares update on CAR T-cell therapies at ASCO meeting
13:00 Allogene (ALLO) Sinks 16% on Downgrade, Trial Delays
07:50 Abrdn Life Sciences Investors Q4 2024 Commentary (NYSE:HQL)

일일 변동 비율

1.11 1.20

년간 변동

0.86 3.78

이전 종가: 1.18
시가: 1.18

Bid: 1.13
Ask: 1.43

저가: 1.11
고가: 1.20

볼륨: 1.878 K

일일 변동: -4.24%
월 변동: -5.83%

6개월 변동: -39.25%
년간 변동율: -56.37%

30 8월, 토요일